Multiple acral fibromas in a patient with familial retinoblastoma: A cutaneous marker of tumour-suppressor gene germline mutation?

British Journal of Dermatology

Volumn 143, Issue 4, 2000, Pages 856-859

  Dereure, O ^a   Savoy, D ^b   Doz, F ^c   Junien, C ^b   Guilhou, J J ^a  

^a HÔPITAL SAINT ELOI   (France)

^b HÔPITAL NECKER ENFANTS MALADES   (France)

^c INSTITUT CURIE   (France)

Author keywords

Fibroma; Nails; RB1 gene; Retinoblastoma

Indexed keywords

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; DISEASE ASSOCIATION; FIBROMA; GENE MUTATION; HETEROZYGOSITY LOSS; HUMAN; MALE; MULTIPLE ENDOCRINE NEOPLASIA; NEUROFIBROMATOSIS; PRIORITY JOURNAL; RETINOBLASTOMA; TUBEROUS SCLEROSIS; TUMOR SUPPRESSOR GENE;

ADULT; FIBROMA; GENES, RETINOBLASTOMA; GERM-LINE MUTATION; HUMANS; LOSS OF HETEROZYGOSITY; MALE; NAIL DISEASES; RETINAL NEOPLASMS; RETINOBLASTOMA; SKIN NEOPLASMS;

EID: 0033744585     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2133.2000.03790.x     Document Type: Article

References (20)

1. Human retinoblastoma susceptibility gene: Cloning, identification and sequence
2. Molecular detection of constitutional deletions in patients with retinoblastoma
3. Three novel germline mutations in exons 8 and 18 of the retinoblastoma gene
4. Second primary tumors in patients with retinoblastoma. A review of the literature
5. Identification of germline mutations in the RB1 gene by denaturing gradient gel electrophoresis and polymerase chain reaction direct sequencing
6. Loss of heterozygosity of the RB gene is a poor prognostic factor in patients with osteosarcoma
7. Loss of heterozygosity and microsatellite instability at the retinoblastoma locus and osteosarcoma
8. Loss of RB and MTS1/CDKN2 (p16) expression in human sarcoma
9. Molecular genetic and immunohistochemical analysis of the tumour suppressor gene Rb and p53 in palmar and aggressive fibromatosis
10. Cytogenetic abnormalities in an ossifying fibroma from a patient with bilateral retinoblastoma
11. Identification of the multiple endocrine neoplasia type 1 (MEN1) gene. The European Consortium on MEN1
12. Hereditary cancer: Two hits revisited
13. Tuberous sclerosis
14. Multiple facial angiofibromas and collagenomas in patients with multiple endocrine neoplasia type 1
15. Constitutional mutations in exon 8 of the p53 gene in patients with multiple primary tumours: Molecular and immunohistochemical findings
16. Cutaneous tumours of patients with multiple endocrine neoplasia type 1 show allelic deletion of the MEN1 gene
17. Benign neurofibromas in type 1 neurofibromatosis (NF1) show somatic deletions of the NF1 gene
18. Confirmation of the double-hit model for the NF1 gene in benign neurofibromas
19. Allelic loss of the NF1 gene in NF1-associated plexiform neurofibromas
20. Loss of heterozygosity in tuberous sclerosis hamartomas